Orbimed Advisors LLC Portfolio Holdings

Orbimed Advisors LLC

  • $4.24 Billion
  • Q3 2024

Orbimed Advisors LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $4.24 Billion distributed in 119 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Edgewise Therapeutics, Inc. with a value of $401M, Eli Lilly & CO with a value of $299M, Boston Scientific Corp with a value of $274M, Intuitive Surgical Inc with a value of $213M, and Biogen Inc. with a value of $158M.

Examining the 13F form we can see an increase of $93.7M in the current position value, from $4.15B to 4.24B.

Orbimed Advisors LLC is based out at San Diego, CA

Below you can find more details about Orbimed Advisors LLC portfolio as well as his latest detailed transactions.

Portfolio value $4.24 Billion
Healthcare: $4.24 Billion

Stock Holdings Table Companies Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$2.02B
$401 Million 9.45% of portfolio
15,021,721
Q1 2024 Added 3.12%
$716B
$299 Million 7.05% of portfolio
337,600
Q2 2024 Reduced 6.43%
$129B
$274 Million 6.46% of portfolio
3,273,000
Q1 2024 Reduced 1.02%
$191B
$213 Million 5.02% of portfolio
433,800
Q3 2024 Reduced 12.03%
$22.5B
$158 Million 3.71% of portfolio
813,000
Q3 2024 Reduced 9.76%
$247B
$149 Million 3.52% of portfolio
1,316,000
Q1 2024 Added 24.74%
$16.4B
$130 Million 3.06% of portfolio
782,000
Q3 2024 Reduced 33.35%
$146B
$124 Million 2.93% of portfolio
344,400
Q3 2024 Added 28.03%
$9.71B
$119 Million 2.81% of portfolio
954,500
Q3 2024 Added 47.76%
$32.7B
$111 Million 2.61% of portfolio
204,500
Q3 2024 Reduced 2.2%
$562B
$105 Million 2.47% of portfolio
179,000
Q3 2024 Added 59.82%
$5.02B
$93.1 Million 2.19% of portfolio
2,324,447
Q3 2024 Reduced 2.02%
$16.3B
$87.4 Million 2.06% of portfolio
687,500
Q2 2024 Reduced 23.56%
$154B
$81.3 Million 1.92% of portfolio
252,300
Q3 2024 Added 87.03%
$469M
$78.3 Million 1.85% of portfolio
5,779,071
Q3 2022 New
$4.42B
$74.8 Million 1.76% of portfolio
575,000
Q3 2024 Added 64.65%
$30.6B
$68.9 Million 1.62% of portfolio
250,300
Q2 2024 New
$211M
$63.1 Million 1.49% of portfolio
7,562,971
Q3 2024 Reduced 0.74%
$1.39B
$59.2 Million 1.39% of portfolio
1,018,734
Q3 2024 Reduced 19.7%
$2.04B
$57.2 Million 1.35% of portfolio
1,258,566
Q3 2024 Reduced 57.76%
$94.5B
$55.2 Million 1.3% of portfolio
106,200
Q3 2024 Reduced 36.82%
$3.01B
$53.6 Million 1.26% of portfolio
1,050,055
Q3 2024 Reduced 18.02%
$201B
$52.2 Million 1.23% of portfolio
84,400
Q3 2024 Reduced 36.06%
$45.5M
$49.7 Million 1.17% of portfolio
73,114,592
Q3 2022 Added 0.23%
$2.28B
$48 Million 1.13% of portfolio
1,044,805
Q3 2024 Added 47.89%
$79.7B
$47.5 Million 1.12% of portfolio
45,200
Q3 2024 Added 98.25%
$1.1B
$47.1 Million 1.11% of portfolio
1,665,115
Q3 2024 Reduced 36.1%
$417M
$46.2 Million 1.09% of portfolio
3,305,801
Q3 2024 Added 2.35%
$9.33B
$46.3 Million 1.09% of portfolio
679,816
Q3 2024 Added 1.1%
$2.34B
$44.6 Million 1.05% of portfolio
1,390,631
Q3 2024 Reduced 18.55%
$5.1B
$44.2 Million 1.04% of portfolio
387,000
Q3 2024 Reduced 51.38%
$139M
$41.1 Million 0.97% of portfolio
22,362,850
Q4 2022 Added 1.83%
$4.69B
$40.5 Million 0.95% of portfolio
766,906
Q3 2024 Reduced 5.66%
$902M
$37.1 Million 0.87% of portfolio
1,925,300
Q2 2024 Added 10.08%
$3.02B
$36.6 Million 0.86% of portfolio
1,270,400
Q3 2024 Reduced 2.49%
$379M
$36.7 Million 0.86% of portfolio
6,943,654
Q3 2021 Reduced 13.78%
$2.45B
$35.9 Million 0.85% of portfolio
911,420
Q3 2024 Added 5.69%
$13B
$35.7 Million 0.84% of portfolio
156,000
Q3 2024 New
$16.6B
$35.6 Million 0.84% of portfolio
123,900
Q3 2024 Reduced 28.83%
$11.8B
$34.8 Million 0.82% of portfolio
302,220
Q3 2024 Reduced 32.57%
$1.24B
$29.9 Million 0.7% of portfolio
675,872
Q1 2024 Reduced 55.48%
$95.9M
$27.6 Million 0.65% of portfolio
6,059,528
Q3 2024 Added 8.99%
$894M
$26.8 Million 0.63% of portfolio
3,573,000
Q3 2024 Added 54.0%
$342M
$26.2 Million 0.62% of portfolio
1,449,073
Q3 2024 New
$1.55B
$25.4 Million 0.6% of portfolio
708,400
Q1 2024 New
$198M
$25 Million 0.59% of portfolio
4,377,900
Q3 2024 Added 189.34%
$230M
$23.7 Million 0.56% of portfolio
3,406,335
Q2 2024 Reduced 14.93%
$595M
$22.9 Million 0.54% of portfolio
2,006,381
Q2 2024 Added 13.37%
$3.34B
$22.8 Million 0.54% of portfolio
435,900
Q3 2024 Reduced 38.16%

Summary

  • Portfolio
  • No. of Stocks 119
  • Current Value $4.24 Billion
  • Prior Value $4.15 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 19 stocks
  • Additional Purchases 19 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 29 stocks
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email